Idiopathic generalized epilepsy

Current Treatment Options in Neurology

Volumn 6, Issue 3, 2004, Pages 231-242

  Sullivan III, Joseph E ^b   Dlugos, Dennis J ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMMONIA; ANTICONVULSIVE AGENT; BENZODIAZEPINE DERIVATIVE; CARBAMAZEPINE; CLONAZEPAM; ETHOSUXIMIDE; ETIRACETAM; FLUOXETINE; FOLIC ACID; LAMOTRIGINE; ORAL CONTRACEPTIVE AGENT; PHENOBARBITAL; PHENYTOIN; PLACEBO; TOPIRAMATE; TRIMETHADIONE; VALPROIC ACID; ZONISAMIDE;

ABSENCE; ACIDOSIS; ALOPECIA; AMBULATORY MONITORING; AMNESIA; ANAMNESIS; ANOREXIA; ATAXIA; BENIGN CHILDHOOD EPILEPSY; BLOOD DYSCRASIA; BODY WEIGHT DISORDER; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; CLOSED ANGLE GLAUCOMA; COGNITIVE DEFECT; DELAYED RELEASE FORMULATION; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIARRHEA; DIFFERENTIAL DIAGNOSIS; DIPLOPIA; DISEASE CLASSIFICATION; DIZZINESS; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG CONTRAINDICATION; DRUG COST; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG ERUPTION; EEG ABNORMALITY; ELECTROENCEPHALOGRAPHY; EVIDENCE BASED MEDICINE; FATIGUE; FOCAL EPILEPSY; GENERALIZED EPILEPSY; HEADACHE; HUMAN; HYPERAMMONEMIA; IDIOPATHIC DISEASE; INCREASED APPETITE; LETHARGY; LIVER TOXICITY; MENSTRUATION DISORDER; MULTICENTER STUDY; MYOCLONUS EPILEPSY; MYOCLONUS SEIZURE; NAUSEA; NEPHROLITHIASIS; NEURAL TUBE DEFECT; PANCREATITIS; PARESTHESIA; PHOTOSENSITIVITY; PHYSICAL EXAMINATION; PSYCHOSIS; RANDOMIZATION; REVIEW; SEDATION; SIDE EFFECT; STEVENS JOHNSON SYNDROME; TABLET FORMULATION; THROMBOCYTE DYSFUNCTION; THROMBOCYTOPENIA; TONIC CLONIC SEIZURE; TREMOR; VOMITING;

EID: 3142691870     PISSN: 10928480     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11940-004-0015-6     Document Type: Review

References (35)

1. Commission on Classification and Terminology of the ILAE: Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 1989, 30:389-399.
2. Faught E: Clinical trials for treatment of primary generalized epilepsies. Epilepsia 2003, 44(suppl):44-50.
3. Loiseau P: Childhood absence epilepsy and related syndromes. In Epileptic Syndromes in Infancy, Childhood, and Adolescence. Edited by Roger J. Eastleigh: John Libbey; 2002:285-303.
4. Commission on Classification and Terminology of the ILAE: Proposal for revised clinical and EEG classification of epileptic seizures. Epilepsia 1981, 22:489-501.
5. Holmes GL, McKeever M, Adamson M: Absence seizures in children: clinical and electroencephalographic features. Ann Neurol 1987, 21:268-273.
6. Thomas P: Juvenile myoclonic epilepsy. Epileptic Syndromes in Infancy, Childhood and Adolescense. Edited by Roger J. Eastleigh: John Libbey, 2002:335-355.
7. Delgado-Escueta AV, Enrile-Bacsal F: Juvenile myoclonic epilepsy of Janz. Neurology 1984, 34:285-294.
8. Wolf P: Epilepsy with grand mal on awakening. In Epileptic Syndromes in Infancy, Childhood and Adolescence. Edited by Roger J. Eastleigh: John Libbey; 2002:357-367.
9. Opp J, Wenzel D, Brandl U: Visuomotor coordination during focal and generalized EEG discharges. Epilepsia 1992, 33:836-840.
10. Lennox W: The petit mal epilepsies: their treatment with Tridione. JAMA 1945, 19:1069-1074.
11. Posner EB, Mohamed K, Marson AG: Ethosuximide sodium valproate or lamotrigine for absence seizures in children and adolescents [Cochrane Review]. In The Cochrane Library. Oxford: Update Software; 2003.
12. Cross JH: Topiramate monotherapy for childhood absence seizures: an open label pilot study. Seizure 2002, 11:406-410.
13. Kotani H, Hirai K, Nishiki T, et al.: Zonisamide monotherapy against absence attacks: report of two cases. Brain Dev 1994, 26:349-354.
14. Browne TR, Dreifuss FE, Dyken PR, et al.: Ethosuximide in the treatment of absence (petit mal) seizures. Neurology 1975, 25:515-524.
15. Sherwin AL, Robb JP, Lechter M: Improved control of epilepsy by monitoring plasma ethosuximide. Arch Neurol 1973, 28:178-181.
16. Villareal HJ, Wilder BJ, Willmore LJ, et al.: Effect of valproic acid on spike and wave discharges in patients with absence seizures. Neurology 1978, 28:886-891.
17. Callaghan N, O'Hare J, O'Driscoll D, et al.: Comparative study of ethosuximide and sodium valproate in the treatment of typical absence seizures. Dev Med Child Neurol 1982, 24:830-836.
18. Sato S, White BG, Penry JK, D et al.: Valproic acid versus ethosuximide in the treatment of absence seizures. Neurology 1982, 32:157-163.
19. Frank LM, Enlow T, Holmes GL, et al.: Lamictal (lamotrigine) monotherapy for typical absence seizures in children. Epilepsia 1999, 40:973-979.
20. Penry JK, Dean JC, Riela AR: Juvenile myolonic epilepsy: long-term response to therapy. Epilepsia. 1989, 30(suppl):S19-S23.
21. Prasad A, Kuzniecky RI, Knowlton RC, et al.: Evolving antiepileptic drug treatment in juvenile myoclonic epilepsy. Arch Neurol 2003, 60:1100-1105.
22. Karlovassitou-Koniari A, Alexiou D, Angelopoulos P, et al.: Low dose sodium valproate in the treatment of juvenile myoclonic epilepsy. J Neurol 2002, 249:396-399.
23. Buchanan N: The use of lamotrigine in juvenile myoclonic epilepsy. Seizure 1996, 5:149-151.
24. Gericke CA, Picard F, de Saint-Martin A, et al.: Efficacy of lamotrigine in idiopathic generalized epilepsy syndromes: a video-EEG-controlled, open study. Epileptic Disord 1999, 1:159-165.
25. Wallace SJ: Myoclonus and epilepsy in childhood: a review of treatment with valproate, ethosuximide, lamotrigine and zonisamide. Epilepsy Res 1998, 29:147-154.
26. Biraben A, Allain H, Scarabin JM, et al.: Exacerbation of juvenile myoclonic epilepsy with lamotrigine. Neurology 2000, 55:1758.
27. Levisohn PM, Holland KD, Hulihan JF, Fisher AC: Topiramate versus valproate in patients with juvenile myoclonic epilepsy. Epilepsia 2003, 44(suppl):267-268.
28. Wheless JW: Use of topiramate in childhood generalized seizure disorders. J Child Neurol 2000, 15(suppl):S7-S13.
29. Doose DR, Wang SS, Padmanabhan M, et al.: Effect of topiramate or carbamazepine on the pharmacokinetics of an oral contraceptive containing norethindrone and ethinyl estradiol in healthy obese and nonobese female subjects. Epilepsia 2003, 44:540-549.
30. Obeid T, Panayiotopoulos CP: Clonazepam in juvenile myoclonic epilepsy. Epilepsia 1989, 30:603-606.
31. Bourgeois B, Beaumanoir A, Blajev B, et al.: Monotherapy with valproate in primary generalized epilepsies. Epilepsia 1987, 28(suppl):S8-S11.
32. Biton V, Montouris GD, Ritter F, et al.: A randomized, placebo-controlled trial of topiramate in primary generalized tonic-clonic seizures. Neurology 1999, 52:1330-1337.
33. Horn CS, Ater SB, Hurst DL: Carbamazepine-exacerbated epilepsy in children and adolescents. Pediatr Neurol 1986, 2:340-345.
34. Genton P: When antiepileptic drugs aggravate epilepsy. Brain Dev 2000, 22:75-80.
35. Genton P, Gelisse P, Thomas P, Dravet C: Do carbamazepine and phenytoin aggravate juvenile myoclonic epilepsy? Neurology 2000, 55:1106-1109.